4.7 Article

Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer

Journal

CANCER LETTERS
Volume 370, Issue 2, Pages 302-312

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2015.10.030

Keywords

Pancreatic adenocarcinoma; Familial pancreatic cancer; Exome sequencing; DNA repair genes

Categories

Funding

  1. Cancer Research Society
  2. National Pancreatic Cancer Canada Foundation
  3. Research Institute McGill University Health Centre
  4. Department of Oncology of the McGill University Health Centre
  5. Goodman Cancer Research Centre
  6. McGill University Innovation Centre
  7. W. Garfield Weston Foundation
  8. Ontario Institute for Cancer Research
  9. National Cancer Institute/National Institutes of Health [R01CA97075]
  10. Cedars Cancer Institute Fellowship
  11. NATIONAL CANCER INSTITUTE [R01CA097075] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The genetic basis underlying the majority of hereditary pancreatic adenocarcinoma (PC) is unknown. Since DNA repair genes are widely implicated in gastrointestinal malignancies, including PC, we hypothesized that there are novel DNA repair PC susceptibility genes. As germline DNA repair gene mutations may lead to PC subtypes with selective therapeutic responses, we also hypothesized that there is an overall survival (OS) difference in mutation carriers versus non-carriers. We therefore interrogated the germline exomes of 109 high-risk PC cases for rare protein-truncating variants (PTVs) in 513 putative DNA repair genes. We identified PTVs in 41 novel genes among 36 kindred. Additional genetic evidence for causality was obtained for 17 genes, with FAN1, NEK1 and RHNO1 emerging as the strongest candidates. An OS difference was observed for carriers versus non-carriers of PTVs with early stage (<= IIB) disease. This adverse survival trend in carriers with early stage disease was also observed in an independent series of 130 PC cases. We identified candidate DNA repair PC susceptibility genes and suggest that carriers of a germline PTV in a DNA repair gene with early stage disease have worse survival. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available